Advertisement

Echocardiographic Findings in HIV-Infected Patients

  • S. Ederhy
  • C. Meuleman
  • N. Haddour
  • G. Dufaitre
  • F. Boccara
  • A. Cohen

Abstract

Echocardiography is an important imaging technique providing real-time imaging that can be performed at the bedside and easily repeated as needed (Table 1). Before the era of highly active anti-retroviral therapy (HAART), cardiac complications in HIV included pericardial effusion, dilated cardiomyopathy, myocarditis, endocarditis, pulmonary hypertension, cardiac neoplasm, coronary artery disease and drug-related cardiotoxicity [1, 2]. Cardiac abnormalities, although usually clinically silent, can be detected in necropsy series in the majority of infected HIV patients (40–60%) [3].

Keywords

Pulmonary Arterial Hypertension Dilate Cardiomyopathy Infective Endocarditis Pericardial Effusion Cardiac Tamponade 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barbaro G (2002) Cardiovascular manifestations of HIV infection. Circulation 106:1420–5CrossRefPubMedGoogle Scholar
  2. 2.
    Fisher SD, Lipshultz SE (2001) Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann NY Acad Sci 946:13–22PubMedCrossRefGoogle Scholar
  3. 3.
    Barbaro G (2003) Evolution of the involvement of the cardiovascular system in HIV infection. Adv Cardiol 40:15–22CrossRefPubMedGoogle Scholar
  4. 4.
    Barbarini G, Barbaro G (2003) Incidence of the involvement of the cardiovascular system in HIV infection. AIDS 17:S46–50Google Scholar
  5. 5.
    Reuter H, Burgess LJ, Doubell AF (2005) Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect 133:393–399CrossRefPubMedGoogle Scholar
  6. 6.
    Heidenreich PA, Eisenberg MJ, Kee LL et al (1995) Pericardial effusion in AIDS: incidence and survival. Circulation 92:3229–3234PubMedGoogle Scholar
  7. 7.
    Chen Y, Brennessel D, Walters J et al (1999) Immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 137:516–521CrossRefPubMedGoogle Scholar
  8. 8.
    Pugliese A, Isnardi D, Saini A et al (2000) Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 40:282–284CrossRefPubMedGoogle Scholar
  9. 9.
    Roy CL, Minor MA, Brookhart MA, Choudhry NK (2007) Does this patient with a pericardial effusion have cardiac tamponade? JAMA 297:1810–1818CrossRefPubMedGoogle Scholar
  10. 10.
    Gowda RM, Khan IA, Sacchi TJ, Vasavada BC (2003) Cardiac tamponade in acquired immunodeficiency syndrome. Int J Cardiol 88:313–314CrossRefPubMedGoogle Scholar
  11. 11.
    Iacobellis G, Pellicelli AM, Sharma AM et al (2007) Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol 99:1470–1472CrossRefPubMedGoogle Scholar
  12. 12.
    Pinamonti B, Alberti E, Cigalotto A et al (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285–289CrossRefPubMedGoogle Scholar
  13. 13.
    Camerini F, Bussani R, Lenarda D et al (1991) Clinical aspects and haemodynamics in the followup of dilated cardiomyopathy and myocarditis. Eur Heart J 12(Suppl D):193–196PubMedGoogle Scholar
  14. 14.
    Hiramitsu S, Morimoto S, Kato S et al (2001) Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study. Jpn Circ 65:863–866CrossRefGoogle Scholar
  15. 15.
    Lieback E, Hardouin I, Meyer R et al (1996) Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. Eur Heart J 17:135–142PubMedGoogle Scholar
  16. 16.
    Felker GM, Boehmer JP, Hruban RH et al (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232CrossRefPubMedGoogle Scholar
  17. 17.
    Mendes LA, Picard MH, Dec GW et al (1999) Ventricular remodeling in active myocarditis: myocarditis treatment trial. Am Heart J 138:303–308CrossRefPubMedGoogle Scholar
  18. 18.
    Thuny F, Avierinos JF, Jop B et al (2006) Images in cardiovascular medicine: massive biventricular thrombosis as a consequence of myocarditis: findings from 2-dimensional and real-time 3-dimensional echocardiography. Circulation 113:e932–933CrossRefPubMedGoogle Scholar
  19. 19.
    Mendes LA, Dec GW, Picard MH et al (1994) Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128:301–307CrossRefPubMedGoogle Scholar
  20. 20.
    Swedberg K, Cleland J, Dargie H et al (2005) Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115–1140CrossRefPubMedGoogle Scholar
  21. 21.
    Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G (1998) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIVpositive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 339:1093–1099CrossRefPubMedGoogle Scholar
  22. 22.
    Cardoso JS, Moura B, Martins L et al (1998) Left ventricular dysfunction in human immunodeficiency virus (HIV) infected patients. Int J Cardiol 63:37–45CrossRefPubMedGoogle Scholar
  23. 23.
    Longo-Mbenza B, Seghers KV, Phuati M et al (1998) Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol 64:63–73CrossRefPubMedGoogle Scholar
  24. 24.
    Twagirumukiza M, Nkeramihigo E, Seminega B et al (2007) Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 5:129–137CrossRefPubMedGoogle Scholar
  25. 25.
    Brown DL, Sather S, Cheitlin MD (1993) Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J 125:1439–1441CrossRefPubMedGoogle Scholar
  26. 26.
    Galia N, Torbicki A, Barst R et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243–2278CrossRefGoogle Scholar
  27. 27.
    Opravil M, Pechere M, Speich R et al (1997) HIV-associated primary pulmonary hypertension: a case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 155:990–995PubMedGoogle Scholar
  28. 28.
    Mesa RA, Edell ES, Dunn WF, Edwards WD (1988) Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc 73:37–45CrossRefGoogle Scholar
  29. 29.
    Petitpretz P, Brenot F, Azarian R et al (1994) Pulmonary hypertension in patients with human immunodeficiency virus infection: comparison with primary pulmonary hypertension. Circulation 89:2722–2727PubMedGoogle Scholar
  30. 30.
    Ehrenreich H, Rieckmann P, Sinowatz F et al (1993) Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol 150:4601–4609PubMedGoogle Scholar
  31. 31.
    Humbert M, Monti G, Fartoukh M et al (1998) Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 11:554–559PubMedGoogle Scholar
  32. 32.
    Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA (2000) HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 118:1133–1141CrossRefPubMedGoogle Scholar
  33. 33.
    Zuber JP, Calmy A, Evison JM et al; Swiss HIV Cohort Study Group (2004) Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 38:1178–1185CrossRefPubMedGoogle Scholar
  34. 34.
    Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMedGoogle Scholar
  35. 35.
    Martinez-Garcia T, Sobrino JM, Pujol E et al (2000) Ventricular mass and diastolic function in patients infected by the humanimmuno deficiency virus. Heart 84:620–624CrossRefPubMedGoogle Scholar
  36. 36.
    Coudray N, de Zuttere D, Force G et al (1995) Ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J 16:61–67PubMedGoogle Scholar
  37. 37.
    Samaan SA, Foster A, Raizada V et al (1995) Myocardial atrophy in acquired immunodeficiency syndrome: associated wasting. Am Heart J 130:823–827CrossRefPubMedGoogle Scholar
  38. 38.
    Meng Q, Lima JA, Lai H, Vlahov D et al (2002) HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 30:306–310PubMedGoogle Scholar
  39. 39.
    Losa JE, Miro JM, Del Rio A et al (2003) Endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect 9:45–54CrossRefPubMedGoogle Scholar
  40. 40.
    De Rosa FG, Cicalini S, Canta F et al (2007) Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIVinfected patients. Infection 35:154–160CrossRefPubMedGoogle Scholar
  41. 41.
    Gebo KA, Burkey MD, Lucas GM et al (2006) Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43:426–432CrossRefPubMedGoogle Scholar
  42. 42.
    Valencia E, Miro J (2004) Endocarditis in the setting of HIV infection. AIDS Rev 6:97–106PubMedGoogle Scholar
  43. 43.
    Horstkotte D, Follath F, Gutschik E et al (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25:267–276CrossRefPubMedGoogle Scholar
  44. 44.
    Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99:962–972CrossRefPubMedGoogle Scholar
  45. 45.
    Khan NU, Ahmed S, Wagner P et al (2004) Cardiac involvement in non-Hodgkin’s lymphoma: with and without HIV infection. Int J Cardiovasc Imaging 20:477–481CrossRefPubMedGoogle Scholar
  46. 46.
    Iwahashi N, Nakatani S, Kakuchi H et al (2005) Cardiac tumor as an initial manifestation of acquired immunodeficiency syndrome. Circ J 69:243–245CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • S. Ederhy
    • 1
  • C. Meuleman
    • 1
  • N. Haddour
    • 1
  • G. Dufaitre
    • 1
  • F. Boccara
    • 1
  • A. Cohen
    • 1
  1. 1.Département de CardiologieAssistance Publique-Hôpitaux de Paris et Université Pierre et Marie Curie, Centre Hospitalier Universitaire Saint-AntoineParisFrance

Personalised recommendations